FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Haw Par Corporation Limited Stock AnalysisComprehensive stock analysis for Haw Par Corporation Limited (HAWPY) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisHAWPY
HAWPY
Haw Par Corporation Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
HAWPY
Home🔹Stocks🔹Haw Par Corporation Limited

Haw Par Corporation Limited

HAWPY•OTC

Haw Par Corporation Limited

HAWPY•OTC
Market cap
$2.96B
Sentiment

Your view on HAWPY

Mkt Cap
$2.96B
Sentiment
Your view
HAWPY
Haw Par Corporation Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
HAWPY
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Haw Par Corporation Limited

Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
Ee Lim Wee
Headquarters
No. 03-03 Haw Par Technocentre, Singapore, SG
Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
Ee Lim Wee
Headquarters
No. 03-03 Haw Par Technocentre, Singapore, SG
Description

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment invests primarily in quoted securities. In addition, the company owns and leases various investment properties that have lettable area of 45,324 square meters of commercial and industrial space in Singapore and Malaysia. Further, the company provides family and tourist oriented leisure alternatives principally in the form of oceanariums. Haw Par Corporation Limited leases land, building, and office space, as well as offers management support services. The company was incorporated in 1969 and is based in Singapore.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News